Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer.

Cansu de MuijnckYoren van GorkomMaurice van DuijvenvoordeMina EghtesadiGeeske Dekker-EnsinkShadhvi S BhairosinghAlessandra AffinitoPeter J K KuppenAlexander L VahrmeijerCornelis F M Sier

Published in: Pharmaceuticals (Basel, Switzerland) (2020)

These data suggest that EphB4 is a promising candidate for targeted image-guided surgery of breast cancer, especially for Her2 negative cases.

Keyphrases